Memphis, TN, United States of America

Chunxu Qu

This inventor holds 1 USPTO granted patent. Top assignee: St. Jude Children's Research Hospital. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chunxu Qu. Retrieved from https://idiyas.com/inventor/chunxu-qu-5n748h4d

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Chunxu Qu in Immunotherapy

Introduction

Chunxu Qu is an accomplished inventor based in Memphis, TN (US). He has made significant contributions to the field of immunotherapy, particularly in analyzing patient responsiveness to treatment. His work is vital in advancing medical research and improving patient outcomes.

Latest Patents

Chunxu Qu holds a patent for "Methods and Kit for Analyzing Responsiveness of Patients to CD19 Immunotherapy." This innovative approach aims to enhance the effectiveness of immunotherapy by providing a better understanding of how patients respond to treatment. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Chunxu Qu is affiliated with St. Jude Children's Research Hospital, where he contributes to groundbreaking research in pediatric medicine. His role at this prestigious institution allows him to collaborate with leading experts in the field, furthering the mission of improving health outcomes for children.

Collaborations

Chunxu Qu has worked alongside notable colleagues such as Charles G Mullighan and Kathryn G Roberts. These collaborations enhance the research environment and foster innovation in the field of immunotherapy.

Conclusion

Chunxu Qu's contributions to immunotherapy exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds the potential to improve the lives of many patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…